Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 5/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | STAT3 | P40763 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.31 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.30 |
| ▸ | PIN4 | Q9Y237 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17515105 | 0.96 | TERT (0.38) | TERTCYP1B1TDP1STAT3HIF1A | |
| SCHEMBL13010656 | 0.94 | TERT (0.32) | TERTCYP1B1TDP1 | |
| SCHEMBL3781232 | 0.89 | CYP1B1 (0.37) | TERTCYP1B1TDP1STAT3HIF1A | |
| SCHEMBL3723988 | 0.86 | CYP1B1 (0.35) | TERTCYP1B1TDP1STAT3HIF1A | |
| SCHEMBL12869446 | 0.85 | TERT (0.36) | TERTCYP1B1STAT3HIF1A | |
| SCHEMBL1793691 | 0.84 | CYP1B1 (0.34) | TERTCYP1B1TDP1STAT3HIF1A | |
| SCHEMBL10819507 | 0.84 | CYP1B1 (0.34) | TERTCYP1B1TDP1STAT3HIF1A | |
| SCHEMBL17514386 | 0.83 | TDP1 (0.37) | TERTTDP1KEAP1NFE2L2TLR9 | |
| SCHEMBL3773226 | 0.83 | SHMT2 (0.34) | TERTCYP1B1TDP1STAT3HIF1A | |
| SCHEMBL13010687 | 0.83 | CYP1B1 (0.33) | TERTCYP1B1TDP1PIN1PIN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| EP-3183757-B1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | CLAP CO LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| US-10454037-B2 | Organic semiconductor composition comprising a liquid medium | BASF SE (DE) | 2019-10-22 | — | — | US | disclosed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| EP-2240970-B1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2018-03-14 | — | — | EP | disclosed |
| US-20170250347-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM | BASF SE (DE) | 2017-08-31 | — | — | US | disclosed |
| US-20170237005-A1 | PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| EP-3183757-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | BASF SE (DE) | 2017-06-28 | — | — | EP | disclosed |
| WO-2016027217-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | BASF SE (DE) | 2016-02-25 | — | — | WO | disclosed |
| US-8404844-B2 | Perylene semiconductors and methods of preparation and use thereof | BASF SE (DE) | 2013-03-26 | — | — | US | disclosed |
| US-8404844-B2 | Perylene semiconductors and methods of preparation and use thereof | BASF SE (DE) | 2013-03-26 | — | — | US | disclosed |
| US-20100319778-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2010-12-23 | — | — | US | disclosed |
| WO-2009098252-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170250347-A1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM | CRY1, NEFM, OR10J3 | TERT 1542/4885CYP1B1 4419/4885TDP1 2275/4885 |
| US-20100319778-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | CDYL, PNN, CPNE4 | TERT 1226/4885CYP1B1 1024/4885TDP1 1957/4885 |
| US-10454037-B2 | Organic semiconductor composition comprising a liquid medium | CRY1, NEFM, OR10J3 | TERT 1542/4885CYP1B1 4419/4885TDP1 2275/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | TERT 2496/4885CYP1B1 3699/4885TDP1 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.